OSLO, NORWAY and METUCHEN, NJ (July 6, 2016) – After investing heavily over the last several years in research and clinical validation of health benefits derived from Vitamin K2, NattoPharma ASA, exclusive supplier of the clinically validated and patented MenaQ7® Vitamin K2 as MK-7, is making strides to grow its global footprint by adding two new team members to its sales force.
Prior to joining Nattopharma as Director of Nordic Accounts and EU Marketing, Gunilla Traberg served 14 years in the international nutraceutical industry with marketing and communications positions in Epax Norway AS, (part of FMC Corporation since 2013), responsible for the branding and marketing of the internationally recognized Epax omega-3 brand. She has acquired considerable experience from managerial roles within B2B and FMCG in marketing, sales, and branding of leading food and household brands, in companies such as Frionor ASA (now part of Findus), Denofa, and Lilleborg Fabrikker AS (now Orkla). Traberg earned her business degree, international study program, from Linköping University, and completed language studies at the University of Aix/Marseille in Aix-and Provence.
Chris Hoover joins NattoPharma’s North American Subisidiary, NattoPharma USA, Inc., as Director of Business Development. Over his 20-year career he has acquired extensive technical knowledge of both ingredients as well as all aspects of finished product manufacturing with companies such as Green Wave Ingredients (GWI), Decas Botanical Synergies, Watson, Inc., and InterHealth Nutraceuticals, Inc. Based in Utah, Hoover is skilled at maintaining multi-million dollar sales territories while cultivating new sales relationships by guiding companies to the ideal ingredient variety and/or manufacturing solution for their desired product application.
“NattoPharma is recognized as the world leader in Vitamin K2 research and development, and commercialization. While our clinically validated and patented MenaQ7 appears in hundreds of products across the globe, we feel strongly that it is time to further that reach for the betterment of worldwide human health,” says Dan Rosenbaum, CEO. “The addition of industry veterans Traberg and Hoover to our already established sales team is an important milestone toward our next phase of growth.”
About NattoPharma & MenaQ7®
NattoPharma ASA, based in Norway, is the world’s leader in vitamin K2 R&D. NattoPharma is the exclusive international supplier of MenaQ7® Vitamin K2 as MK-7, the best documented, commercially available Vitamin K2 as MK-7 with guaranteed actives and stability, clinical substantiation, and international patents granted and pending. The company has a multi-year research and development program to substantiate and discover the health benefits of vitamin K2 for applications in the marketplace for functional food and dietary supplements. With a global presence, the company established its North American subsidiary, NattoPharma USA, Inc., in Metuchen, NJ. For more information, visit nattopharma.com or menaq7.com.